FI913899A0 - THERAPEUTIC AEROSOLBLANDNINGAR. - Google Patents

THERAPEUTIC AEROSOLBLANDNINGAR.

Info

Publication number
FI913899A0
FI913899A0 FI913899A FI913899A FI913899A0 FI 913899 A0 FI913899 A0 FI 913899A0 FI 913899 A FI913899 A FI 913899A FI 913899 A FI913899 A FI 913899A FI 913899 A0 FI913899 A0 FI 913899A0
Authority
FI
Finland
Prior art keywords
aerosolblandningar
therapeutic
therapeutic aerosolblandningar
Prior art date
Application number
FI913899A
Other languages
Finnish (fi)
Inventor
George Robert Felt
Mark Peter Warchol
Original Assignee
Rorer Int Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rorer Int Holdings filed Critical Rorer Int Holdings
Publication of FI913899A0 publication Critical patent/FI913899A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/23Calcitonins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI913899A 1989-02-23 1991-08-19 THERAPEUTIC AEROSOLBLANDNINGAR. FI913899A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31460589A 1989-02-23 1989-02-23
PCT/US1990/000928 WO1990009781A1 (en) 1989-02-23 1990-02-21 Therapeutic aerosol formulations

Publications (1)

Publication Number Publication Date
FI913899A0 true FI913899A0 (en) 1991-08-19

Family

ID=23220626

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913899A FI913899A0 (en) 1989-02-23 1991-08-19 THERAPEUTIC AEROSOLBLANDNINGAR.

Country Status (6)

Country Link
EP (1) EP0460064A4 (en)
JP (1) JPH05508616A (en)
AU (1) AU5194990A (en)
CA (1) CA2050905A1 (en)
FI (1) FI913899A0 (en)
WO (1) WO1990009781A1 (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2097932A1 (en) * 1991-10-11 1993-04-12 Shojiro Yamazaki Antibody containing composition
ATE146359T1 (en) * 1992-01-21 1997-01-15 Stanford Res Inst Int IMPROVED METHOD FOR PRODUCING MICRONIZED POLYPEPTIDE DRUGS
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5698672A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Synthetic calcitonin mimetics
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
DE19733651A1 (en) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Aqueous aerosol preparations containing biologically active marrow molecules and processes for producing corresponding aerosols
GB9807232D0 (en) * 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6136294C1 (en) * 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation
US6458338B1 (en) * 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
US6540982B1 (en) 2000-01-25 2003-04-01 Aeropharm Technology Incorporated Medical aerosol formulation
US6540983B1 (en) 2000-01-25 2003-04-01 Aeropharm Technology Incorporated Medical aerosol formulation
US6585957B1 (en) 2000-01-25 2003-07-01 Aeropharm Technology Incorporated Medicinal aerosol formulation
US6565833B1 (en) 2000-05-01 2003-05-20 Aeropharm Technology Incorporated Medicinal aerosol formulation
US6468507B1 (en) 2000-05-01 2002-10-22 Aeropharm Technology, Inc. Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer
US6548049B1 (en) 2000-05-01 2003-04-15 Aeropharm Technology Incorporated Medicinal aerosol formulation
US6464959B1 (en) 2000-05-01 2002-10-15 Aeropharm Technology Incorporated Non-aqueous aerosol suspension comprising troglitazone, a fluid propellant, and an amino acid stabilizer
US6749845B2 (en) 2001-02-15 2004-06-15 Aeropharm Technology, Inc. Modulated release particles for lung delivery
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP2010534248A (en) 2007-07-21 2010-11-04 アルバニー モレキュラー リサーチ, インコーポレイテッド 5-pyridinone substituted indazole
EP2222639A1 (en) 2007-11-21 2010-09-01 Decode Genetics EHF Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
ES2523580T3 (en) 2008-01-11 2014-11-27 Albany Molecular Research, Inc. Pyridoindoles substituted with (1-Azinone)
US8297305B2 (en) 2008-01-28 2012-10-30 Kohler Co. Valve assembly having an improved flow path
WO2010059836A1 (en) 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
RU2506266C2 (en) 2009-01-26 2014-02-10 Израэл Инститьют Фо Байолоджикал Рисерч Bicyclic heterocyclic spirocompounds
WO2010112358A2 (en) 2009-03-31 2010-10-07 Boehringer Ingelheim International Gmbh Method for coating a surface of a component
JP5763053B2 (en) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Adapter, inhaler and atomizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EA026241B1 (en) 2009-11-25 2017-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Nebulizer
JP5658268B2 (en) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
JP5874724B2 (en) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
WO2012130757A1 (en) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
NZ724449A (en) 2014-05-07 2022-01-28 Boehringer Ingelheim Int Nebulizer and container
DK3139979T3 (en) 2014-05-07 2023-10-09 Boehringer Ingelheim Int DEVICE, ATOMIZER AND PROCEDURE
EP3139984B1 (en) 2014-05-07 2021-04-28 Boehringer Ingelheim International GmbH Nebulizer
EP3768267A4 (en) 2018-03-20 2022-04-20 Icahn School of Medicine at Mount Sinai Kinase inhibitor compounds and compositions and methods of use
KR20210042412A (en) 2018-09-06 2021-04-19 주식회사 이노파마스크린 Methods and compositions for treatment of asthma or Parkinson's disease
CN113508111A (en) 2018-12-31 2021-10-15 西奈山伊坎医学院 Kinase inhibitor compounds and compositions and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE556587A (en) * 1957-01-31 1957-04-11
US3169095A (en) * 1962-10-30 1965-02-09 Rexall Drug Chemical Self-propelling powder-dispensing compositions
US4241051A (en) * 1977-11-04 1980-12-23 Christie Robert B Calcitonin
JPS60161924A (en) * 1984-02-01 1985-08-23 Fujisawa Pharmaceut Co Ltd Composition for lung absorption
JPS61267528A (en) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd Transnasal calcitonin agent containing absorbefacient
WO1986006959A1 (en) * 1985-05-22 1986-12-04 Liposome Technology, Inc. Liposome inhalation method and system
HUT44794A (en) * 1985-12-04 1988-04-28 Sandoz Ag Process for production of calcitonine-derivatives and medical preparatives containing such compounds
US5059587A (en) * 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration

Also Published As

Publication number Publication date
EP0460064A1 (en) 1991-12-11
WO1990009781A1 (en) 1990-09-07
AU5194990A (en) 1990-09-26
CA2050905A1 (en) 1990-08-24
EP0460064A4 (en) 1992-04-01
JPH05508616A (en) 1993-12-02

Similar Documents

Publication Publication Date Title
FI906367A (en) THERAPEUTIC NUCLEOSIDER.
FI913899A0 (en) THERAPEUTIC AEROSOLBLANDNINGAR.
ATE120194T1 (en) THERAPEUTIC NULEOSIDES.
FI903656A0 (en) THERAPEUTIC KINUCLIDIN INFOERING.
FI883757A0 (en) THERAPEUTIC NUCLEOSIDER.
FI881651A0 (en) THERAPEUTIC NUCLEOSIDER.
DE59007974D1 (en) Uretero-renoscope.
FI904854A0 (en) THERAPEUTIC NUCLEOSIDER.
FI902973A0 (en) MAGNETFAELTSGENERATOR FOER THERAPEUTIC AENDAMAOL.
FI893897A0 (en) THERAPEUTIC NUCLEOSIDER.
FI923486A (en) THERAPEUTIC AEMNEN.
FI881216A (en) THERAPEUTIC NUCLEOSIDER.
FI894321A0 (en) THERAPEUTIC AEMNEN.
FI910753A0 (en) THERAPEUTIC NUCLEOCIDER.
DE69005107D1 (en) FOOTCROSS.
FI923528A0 (en) THERAPEUTIC AEMNEN.
FI912852A0 (en) THERAPEUTIC DECAPEPTIDER.
NO901573L (en) THERAPEUTIC AGENTS.
NO901574D0 (en) THERAPEUTIC AGENTS.
ES1011811Y (en) MUNECO-CONTAINER.
ES1012497Y (en) ALTERNATOR-DEPRESSOR.
ES1008798Y (en) BAG-BACKPACK.
FI892374A0 (en) ANORDNING FOER FOERFLYTTNING AV PATIENT.
FI891231A0 (en) ANORDNING FOER FOERFLYTTNING AV PATIENT.
FI890114A (en) LAOSMEKANMM FOER STAEMTAPP.

Legal Events

Date Code Title Description
FD Application lapsed